Greenwood Capital Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Greenwood Capital Associates's AMGN Position: Q2 2026 in Review
Greenwood Capital Associates reduced its Amgen (AMGN) stake by 0.9% in Q2 2026, selling an estimated $94.1K and leaving 30,169 shares worth $10.9M. The position accounts for 1.07% of the portfolio, ranked #20.
Greenwood Capital Associates first reported a position in AMGN in Q2 2013 and has held it in 25 quarters since. The position peaked at $16.8M in Q3 2024. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Greenwood Capital Associates held 30,169 shares of Amgen worth $10.9M as of Q2 2026.
- Greenwood Capital Associates sold 275 Amgen shares in Q2 2026, an estimated $94.1K.
- Amgen made up 1.07% of Greenwood Capital Associates's portfolio in Q2 2026, its #20 holding.
- Greenwood Capital Associates first reported a position in Amgen in Q2 2013 and has held it in 25 quarters since.
- Greenwood Capital Associates's Amgen position peaked at $16.8M in Q3 2024.
- 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Greenwood Capital Associates's 13F filing for Q2 2026, filed 28 Jul 2026.